Study: Omicron evades some but not all monoclonal antibodies
Por um escritor misterioso
Descrição
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.
Covid-19] Omicron : resistant to most monoclonal antibodies but neutralized by a booster dose
Advances in the Omicron variant development - Vitiello - 2022 - Journal of Internal Medicine - Wiley Online Library
The Omicron Variant Partly Dodged Vaccines In A Blood Study
COVID, Free Full-Text
COVID-19: Omicron may not evade all monoclonal antibodies, says study - BusinessToday
Monoclonal antibodies
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic - ScienceDirect
New study forecasts how SARS-CoV-2 variants could evade vaccines — Harvard Gazette
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months - eBioMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
